Barry Investment Advisors, LLC Astrazeneca PLC Transaction History
Barry Investment Advisors, LLC
- $423 Million
- Q3 2025
A detailed history of Barry Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Barry Investment Advisors, LLC holds 3,962 shares of AZN stock, worth $354,202. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,962
Previous 4,002
1.0%
Holding current value
$354,202
Previous $279,000
8.6%
% of portfolio
0.07%
Previous 0.07%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...